Unlock All Angles.
Published loading...Updated

Moderna posts quarterly loss, citing seasonality in respiratory business

Summary by Globo
The company said it expects about $200 million in revenue in the first half of 2025, reflecting the seasonality of its respiratory business.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Globo broke the news in Brazil on Thursday, May 1, 2025.
Sources are mostly out of (0)